Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

PEAR1 Promotes Glucose Metabolism Reprogramming in Sepsis-Associated Acute Lung Injury via AARS1-Mediated HIF-1α Lactylation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Manganese(II) Oxidation and Mineralization by the Deep-Sea Bacterium Shewanella piezotolerans WP3.

Geobiology·2026
Same author

Single-Cell Reveal GALNT7-Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non-Small Cell Lung Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Multimodal Nanobubbles Carrying Indocyanine Green and VCAM-1 Targeting Peptide for Molecular Imaging of DOX-Induced Cardiotoxicity.

International journal of nanomedicine·2026
Same author

Targeting immunoglobulin superfamily member 9 (IGSF9) to overcome acute myeloid leukemia resistance to CAR-T therapy.

Journal of experimental & clinical cancer research : CR·2026
Same author

Removing Pb<sup>2+</sup> ions from aqueous solution with freshwater cyanobacteria: Combined adsorption and intracellular precipitation.

Journal of hazardous materials·2026

相关实验视频

Updated: Jul 5, 2025

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-&#947;-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

11.1K

原生动物衍生的细胞因子-转基因巨逆转肝纤维化

Ying Chen1,2,3, Jie Wang1,2, Nan Zhou1,2

  • 1Department of Biochemistry and Molecular Biology, Research Center for Infectious Diseases, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 22, 2024
PubMed
概括

通过改善免疫细胞的招募和功能,表达Toxoplasma gondii细胞因子的工程巨细胞提供了更安全,更有效的肝纤维化治疗方法. 这种新的方法增强了基于巨细胞的免疫疗法,用于治疗肝纤维化.

关键词:
这种毒性淋巴细胞 (Toxoplasma gondii) 是托克索普拉斯马淋迪巨细胞迁移抑制因素免疫疗法 免疫疗法肝脏纤维化 肝脏纤维化巨细胞是什么?巨细胞是什么?两极分化是一种极化.

更多相关视频

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

25.3K
Depletion and Reconstitution of Macrophages in Mice
08:50

Depletion and Reconstitution of Macrophages in Mice

Published on: August 1, 2012

39.7K

相关实验视频

Last Updated: Jul 5, 2025

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-&#947;-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

11.1K
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

25.3K
Depletion and Reconstitution of Macrophages in Mice
08:50

Depletion and Reconstitution of Macrophages in Mice

Published on: August 1, 2012

39.7K

科学领域:

  • 免疫学 免疫学 免疫学
  • 细胞生物学 细胞生物学
  • 寄生虫学的寄生虫学

背景情况:

  • 巨细胞治疗对肝纤维化有希望,但需要更安全,更明确的细胞表型.
  • 巨细胞异质性在肝纤维化中对一致的治疗结果提出了挑战.

研究的目的:

  • 开发一种新的基于巨细胞的肝纤维化免疫疗法.
  • 为了设计具有表达Toxoplasma gondii的关键细胞因子的稳定表现型的巨细胞.

主要方法:

  • 生成的转基因巨细胞 (Mφtgmif) 表示Toxoplasma gondii巨细胞迁移抑制因子 (TgMIF).
  • 评估了Mφtgmif的纤维分析和化学反应能力.
  • 评估了Mφtgmif在改善肝纤维化中的有效性.
  • 研究了Mφtgmif的作用机制,包括免疫细胞的招募和两极分化.

主要成果:

  • Mφtgmif表现出稳定的纤维解和增强的化学反应能力.
  • Mφtgmif通过通过CCL2和CX3CL1.1招募和两极化内源性巨细胞,有效降低了肝纤维化.
  • 激活ERK/HMGB1/NF-κB通路的TgMIF促进了CCL2表达,增强了巨细胞的招募.
  • 与LPS/IFN-γ治疗的巨细胞相比,Mφtgmif表现出优越的治疗效果,更高的化学作用和更低的炎症.

结论:

  • 工程Mφtgmif为肝纤维化提供了更安全,更有效的基于巨细胞的免疫治疗.
  • 作为一个进化设计的免疫调节剂,TgMIF可改变肝脏的免疫微环境.
  • 这一策略为治疗肝纤维化和潜在的其他人类疾病提供了一种可行的方法.